Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 5,600,193 $ 7,591,601
General and administrative 3,231,042 2,945,276
Total operating expenses 8,831,235 10,536,877
Loss from operations (8,831,235) (10,536,877)
Interest income 429,039 21,239
Net loss (8,402,196) (10,515,638)
Other comprehensive income (loss):    
Foreign currency translation loss (17,272) (2,937)
Unrealized (loss) gain on investments (5,802) 15,039
Comprehensive loss $ (8,425,270) $ (10,503,536)
Net loss per share:    
Basic and diluted (in dollars per share) $ (0.61) $ (0.83)
Weighted average shares outstanding:    
Basic and diluted (in shares) 13,823,951 12,718,166